Tech Company Financing Transactions
Atrandi Biosciences Funding Round
Atrandi Biosciences, based in Vilnius, Vilniaus Apskritis, secured $25 million in funding from Lux Capital, GRIDS Capital and Metaplanet.
Transaction Overview
Company Name
Announced On
2/19/2025
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Proceeds Purpose
This investment will accelerate the company's expansion into the U.S. market, support the growth of its semi-permeable capsule (SPC) technology, and advance new product development to enable breakthrough scientific discoveries.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Vilnius, Vilniaus Apskritis, Undisclosed
Lithuania
Vilnius, Vilniaus Apskritis, Undisclosed
Lithuania
Phone
Undisclosed
Website
Email Address
Overview
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Juozas Nainys
Chief Scientific Officer
Rapolas Zilionis
Chief Technical Officer
Karolis Leonavicius
Browse more venture capital transactions:
Prev: 2/19/2025: Augury venture capital transaction
Next: 2/19/2025: Lumotive venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs